Patent ID: 8546419

Claim:
A compound of formula: wherein: M is a chemotherapeutic agent selected from the group consisting doxorubicin, cisplastin, carboplatin, vincristine, mitromycine, camptothecin, and illudin; q is an integer from 0-4; and each occurrence of R 2 is independently hydrogen, halogen, —CN, NO 2 , an aliphatic, alicyclic, heteroaliphatic, heterocyclic, aryl, or heteroaryl moiety, or -GR G1 wherein G is —O—, —S—, —NR G2 —, —C(═O)—, —S(═O)—, —SO 2 —, —C(═O)O—, —C(═O)NR G2 —, —OC(═O)—, —NR G2 C(═O)—, —OC(═O)O—, —OC(═O)NR G2 —, —NR G2 C(═O)O—, —NR G2 C(═O)NR G2 —, —C(═S)—, —C(═S)S—, —SC(═S)—, —SC(═S)S—, —C(═NR G2 )—, —C(═NR G2 )O—, —C(═NR G2 )NR G3 —, —OC(═NR G2 )—, —NR G2 C(═NR G3 )—, —NR G2 SO 2 —, —NR G2 SO 2 NR G3 —, or —SO 2 NR G2 —, wherein each occurrence of R G1 , R G2 and R G3 is independently hydrogen, halogen, or an optionally substituted aliphatic, heteroaliphatic, alicyclic, heteroalicyclic, aryl or heteroaryl moiety.